Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg
- PMID: 1323143
- DOI: 10.1126/science.1323143
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg
Abstract
Antigen-specific T cell activation depends on T cell receptor-ligand interaction and costimulatory signals generated when accessory molecules bind to their ligands, such as CD28 to the B7 (also called BB1) molecule. A soluble fusion protein of human CTLA-4 (a protein homologous to CD28) and the immunoglobulin (lg) G1 Fc region (CTLA4lg) binds to human and murine B7 with high avidity and blocks T cell activation in vitro. CTLA4lg therapy blocked human pancreatic islet rejection in mice by directly affecting T cell recognition of B7+ antigen-presenting cells. In addition, CTLA4lg induced long-term, donor-specific tolerance, which may have applications to human organ transplantation.
Comment in
-
Mounting a targeted strike on unwanted immune responses.Science. 1992 Aug 7;257(5071):751. doi: 10.1126/science.1323142. Science. 1992. PMID: 1323142 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
